{"summary":"18-year early-stage venture capital investor in technology and healthcare; \nPart-time doctoral student with the Bloomberg School of Public Health, Johns Hopkins University","lastName":"Li","objectUrn":"urn:li:member:11349805","geoRegion":"Cleveland, Ohio, United States","fullName":"Linda Li","firstName":"Linda","currentPositions":[{"companyName":"Cleveland Clinic","title":"Partner","tenureAtCompany":{"numYears":1,"numMonths":6},"companyUrnResolutionResult":{"employeeCountRange":"10001+","headquarters":{"geographicArea":"Ohio","country":"United States","city":"Cleveland","line1":"9500 Euclid Ave"},"website":"http:\/\/www.clevelandclinic.org\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/cleveland-clinic\/","industry":"Hospitals and Health Care"},"startedOn":{"month":12,"year":2022},"companyUrn":"urn:li:fs_salesCompany:5656"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAACtLy0BmUKWANg0AvXmobZTy80y8ED5eOg,NAME_SEARCH,s-CN)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1672418283892?e=1723075200&v=beta&t=RV_L_6G3zLR9z2swSxFoo5s-7wkIbwXDQaISmPlzr1c","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1672418283892?e=1723075200&v=beta&t=giZHtjvs-xZD5LXKlF1KVw5xbSjA-fxbueq2U_Jsjw8","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1672418283892?e=1723075200&v=beta&t=woWG3-4CXo482qUtfQ0v9_7ACzFS8snbNvg11PY4BGo","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1672418283892?e=1723075200&v=beta&t=K_Uod1rmJoKZcFCDNiEOR-vcrwFY7YN9EKGmEFvLvvQ","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D5603AQGy2w1lf6GumA\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{"socialHandles":[{"type":"WECHAT","name":"linda-hongxia","dataSource":"LINKEDIN"}]},"industry":"Hospitals and Health Care","educations":[{"endedOn":{"month":7,"year":2026},"degree":"DrPH student, Bloomberg School of Public Health","eduId":770426556,"schoolUrn":"urn:li:fs_salesSchool:3528","school":"urn:li:fs_salesSchool:3528","fieldsOfStudy":["Implementation Science"],"schoolName":"The Johns Hopkins University","startedOn":{"month":6,"year":2021}},{"endedOn":{"month":7,"year":2013},"schoolName":"Kauffman Fellowship Program","startedOn":{"month":7,"year":2011},"eduId":845740597},{"endedOn":{"year":2003},"degree":"Master's degree","eduId":8227508,"schoolUrn":"urn:li:fs_salesSchool:5524","school":"urn:li:fs_salesSchool:5524","schoolName":"National University of Singapore","startedOn":{"year":2002}},{"endedOn":{"year":2002},"degree":"Bachelor's degree","eduId":7656976,"schoolUrn":"urn:li:fs_salesSchool:20289","school":"urn:li:fs_salesSchool:20289","schoolName":"Peking University","startedOn":{"year":1998}},{"endedOn":{"year":1998},"degree":"High School Diploma","eduId":169806068,"schoolUrn":"urn:li:fs_salesSchool:35576723","school":"urn:li:fs_salesSchool:35576723","schoolName":"Tianjin Yaohua High School","startedOn":{"year":1995}}],"skills":[{"numOfEndorsement":22,"name":"Due Diligence"},{"numOfEndorsement":38,"name":"Venture Capital"},{"numOfEndorsement":44,"name":"Investments"},{"numOfEndorsement":9,"name":"Chinese"},{"numOfEndorsement":15,"name":"Financial Modeling"},{"numOfEndorsement":1,"name":"Alternative Investments"},{"numOfEndorsement":3,"name":"Asset Management"},{"numOfEndorsement":17,"name":"Emerging Markets"},{"numOfEndorsement":6,"name":"IPO"},{"numOfEndorsement":1,"name":"Financial Structuring"},{"numOfEndorsement":7,"name":"Valuation"},{"numOfEndorsement":9,"name":"Portfolio Management"},{"numOfEndorsement":8,"name":"Investment Banking"},{"numOfEndorsement":4,"name":"Financial Services"},{"numOfEndorsement":6,"name":"Corporate Finance"},{"numOfEndorsement":1,"name":"Bloomberg"},{"numOfEndorsement":2,"name":"Investor Relations"},{"numOfEndorsement":3,"name":"M&A experience"},{"numOfEndorsement":1,"name":"Joint Ventures"},{"numOfEndorsement":5,"name":"Business Strategy"},{"numOfEndorsement":3,"name":"Financial Analysis"},{"numOfEndorsement":1,"name":"Investment Management"},{"numOfEndorsement":4,"name":"Strategy"},{"numOfEndorsement":1,"name":"Economics"},{"numOfEndorsement":1,"name":"Deal Sourcing"},{"numOfEndorsement":1,"name":"Equity Research"},{"numOfEndorsement":4,"name":"Corporate Development"},{"numOfEndorsement":5,"name":"Entrepreneurship"},{"numOfEndorsement":1,"name":"Project Finance"},{"numOfEndorsement":3,"name":"International Business"},{"numOfEndorsement":3,"name":"Management Consulting"},{"numOfEndorsement":2,"name":"Hedge Funds"},{"numOfEndorsement":1,"name":"Private Placements"},{"numOfEndorsement":1,"name":"Market Entry"},{"numOfEndorsement":4,"name":"Equities"},{"numOfEndorsement":1,"name":"LBO"},{"numOfEndorsement":1,"name":"Business Valuation"},{"numOfEndorsement":1,"name":"Structured Finance"},{"numOfEndorsement":2,"name":"Restructuring"},{"numOfEndorsement":1,"name":"Growth Capital"},{"numOfEndorsement":2,"name":"Capital Markets"}],"numOfConnections":2226,"patents":[],"headline":"Partner, Cleveland Clinic Ventures;","courses":[{"name":"Kauffman Fellowship","number":"Class 16"}],"certifications":[{"authority":"CFA Institute","name":"Chartered Financial Analyst (CFA)","company":"urn:li:fs_salesCompany:162977","startedOn":{"month":9,"year":2011},"companyUrn":"urn:li:fs_salesCompany:162977"}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/ccflinda","organizations":[],"location":"Cleveland, Ohio, United States","publications":[],"positions":null,"posts":[{"createdAt":1712109120000,"insightId":"a80b5447-50b7-4f8d-8afc-8ad35022945f","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":17},{"type":"PRAISE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7181106316210323459","threadUrn":"urn:li:activity:7181106316210323459","reactionsCount":19,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7181106315291762688","message":{"attributes":[{"start":269,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:80965"}}},{"start":282,"length":28,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:15158066"}}},{"start":311,"length":6,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:15079269"}}},{"start":318,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:252736"}}}],"text":"Was thrilled to work with the Cleveland Clinic Innovations team. Look forward to continuing our endeavor in the neurodivergent space with Floreo team. Thanks, JD, for driving the effort in the earlier stage and opening the Autism Awareness month with a great release! \nJD Friedland Cleveland Clinic Innovations Floreo Vijay Ravindran"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"title":{"text":"Autism Eyes_IMAGE"},"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D5610AQFFuwVKogYtPQ\/image-shrink_1280\/0\/1712089893111?e=1717977600&v=beta&t=hQxHECmjnV4pgqEjFO1n8cISd6LUgG3pZXVQS1Q4uFc"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7181025509303099393","message":{"attributes":[{"start":163,"length":16,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:5656"}}},{"start":263,"length":6,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:15079269"}}},{"start":283,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:252736"}}},{"start":506,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:73399078"}}},{"start":532,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:543938174"}}},{"start":864,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:15544476"}}},{"start":1451,"length":26,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:55052886"}}},{"start":1485,"length":25,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/hubs.li\/Q02ry-HZ0"}}},{"start":1513,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:innovation"}}},{"start":1525,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:autism"}}},{"start":1533,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:neurodiversity"}}},{"start":1549,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:digitalhealth"}}},{"start":1564,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:healthtech"}}},{"start":1576,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:behavioralhealth"}}},{"start":1594,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:clevelandclinic"}}},{"start":1611,"length":21,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:autismawarenessmonth"}}},{"start":1633,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:virtualreality"}}}],"text":"Congratulations to Autism Eyes, an autism diagnostics and assessment company created by Cleveland Clinic Innovations with intellectual property (IP) licensed from Cleveland Clinic, which has been acquired by the behavioral health-focused virtual reality company, Floreo, led by CEO, Vijay Ravindran. This news coincides with an announcement that Cleveland Clinic has made a strategic investment in Floreo. The technology was invented by former Cleveland Clinic clinical psychologist and autism researcher, Tom Frazier, II, PhD, and Eric Klingemier. A new exclusive license between Cleveland Clinic and Floreo has been entered to transfer the IP.\n \n\"The rising incidence of autism demands cutting-edge technology solutions to help individuals and their families, and Cleveland Clinic remains committed to driving innovations in autism treatment and services,\u201d said Geoff Vince, PhD, Executive Director of Cleveland Clinic Innovations. \u201cFloreo\u2019s VR platform combined with the eye-tracking diagnostic capabilities of Autism Eyes will help build an integrated pathway tailored to each individual\u2019s needs.\u201d\n \nFloreo uses a virtual reality platform to help neurodiverse individuals develop new skills. The platform allows therapists to provide customized lessons to meet clients\u2019 needs. The technology can be used in therapy, educational, or family settings. We are thrilled that this acquisition will help bolster Floreo's autism services!\n \nRead the full Behavioral Health Business piece: https:\/\/hubs.li\/Q02ry-HZ0\n \n#innovation #autism #neurodiversity #digitalhealth #healthtech #behavioralhealth #clevelandclinic #autismawarenessmonth #virtualreality"},"entityUrn":"urn:li:share:7181025509303099393"},"entityUrn":"urn:li:share:7181106315291762688"}}}]}